These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Immunopharmacologic treatment of 9 digitalis poisonings in children with sheep antidigoxin Fab]. Smolarz A; Abshagen U Monatsschr Kinderheilkd; 1985 Sep; 133(9):682-7. PubMed ID: 4058431 [TBL] [Abstract][Full Text] [Related]
7. Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments. Wenger TL; Butler VP; Haber E; Smith TW J Am Coll Cardiol; 1985 May; 5(5 Suppl A):118A-123A. PubMed ID: 3886748 [TBL] [Abstract][Full Text] [Related]
8. Endogenous cardiac glycoside-like substances in newborns, adults, pregnant women and patients with hypertension or renal insufficiency. Clerico A; Balzan S; Del Chicca MG; Paci A; Cocci F; Bertelli A Drugs Exp Clin Res; 1988; 14(9):603-7. PubMed ID: 3229323 [TBL] [Abstract][Full Text] [Related]
9. Topics in neonatal metabolism. Metabolic effects of digitalis intoxication in a premature infant: treatment with digoxin-specific Fab fragments. Telang V; Woolf P J Perinatol; 1987; 7(3):259-61. PubMed ID: 2848937 [No Abstract] [Full Text] [Related]
10. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. Antman EM; Wenger TL; Butler VP; Haber E; Smith TW Circulation; 1990 Jun; 81(6):1744-52. PubMed ID: 2188752 [TBL] [Abstract][Full Text] [Related]
14. Factors of importance for valid digitalis assays particularly for the determination of digoxin in plasma and urine. Molin L Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 4():1-62. PubMed ID: 3739734 [TBL] [Abstract][Full Text] [Related]
15. [Endogenous digitalis-like substances in umbilical cord blood: analytical interference or new hormones?]. Sandouk P; Scherrmann JM; Barrier J; Ciraru-Vigneron N; Guedeney X; Bourdon R J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):737-42. PubMed ID: 3794210 [TBL] [Abstract][Full Text] [Related]
16. Increased digitalis-like immunoreactive substances in patients with hypertrophic cardiomyopathy. Hayashi T; Ijiri Y; Toko H; Shimomura H; Okabe M; Terasaki F; Kitaura Y; Kawamura K Eur Heart J; 2000 Feb; 21(4):296-305. PubMed ID: 10653677 [TBL] [Abstract][Full Text] [Related]
17. New advances in the assessment and treatment of digitalis toxicity. Smith TW J Clin Pharmacol; 1985 Oct; 25(7):522-8. PubMed ID: 2999197 [TBL] [Abstract][Full Text] [Related]
18. Treatment of digitalis intoxication with emphasis on the clinical use of digoxin immune Fab. Allen NM; Dunham GD DICP; 1990 Oct; 24(10):991-8. PubMed ID: 2244414 [TBL] [Abstract][Full Text] [Related]
19. Steady state serum digoxin concentration in relation to digitalis toxicity in neonates and infants. Halkin H; Radomsky M; Blieden L; Frand M; Millman P; Boichis H Pediatrics; 1978 Feb; 61(2):184-8. PubMed ID: 634668 [TBL] [Abstract][Full Text] [Related]
20. Action of digitalis in latent cardiac failure. SELZER A Calif Med; 1963 Jan; 98(1):1-6. PubMed ID: 13987866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]